Navigation Links
Berkery Noyes Releases 2011 Pharma & Healthcare Information and Technology Industry Mergers & Acquisitions Report
Date:1/19/2012

NEW YORK, Jan. 19, 2012 /PRNewswire/ -- Berkery Noyes, an independent middle market investment bank, today released its 2011 Full Year Mergers and Acquisitions trend report for the Pharma & Healthcare Information and Technology Industry.

The report analyzes the sector for 2011 and compares it with similar activity in 2009 and 2010. This market includes information and technology companies servicing pharmaceutical, healthcare payer, and healthcare provider companies.

Blackstone Group LP's acquisition of Emdeon, Inc. was the largest transaction for 2011, with an acquisition price of $3.03 billion. In terms of transaction type, 22% of industry deals were financed by private equity, venture capital, and other investment firms.

"In 2011, M&A-driven expansion of strategic healthcare technology and information platforms by major players, some private equity-backed, continued as a dominant trend," stated Jeffrey Smith, Managing Director in Berkery Noyes' Healthcare and Life Sciences group. "This trend will continue in 2012, offering an active market, competitive sales processes, and excellent valuation opportunities for independently-owned companies providing software, information, data, communications and services solutions to the healthcare and life science industries."

Median revenue and EBITDA multiples fell from 2010 to 2011. The median revenue multiple decreased from 2.0x to 1.6x, while the median EBITDA multiple went from 11.6x to 9.0x. Although total transaction value declined 9 percent over the last twelve months, total transaction volume increased 15 percent, from 255 to 292 this year.

Based on value, the most active market segment that Berkery Noyes tracked between 2009 and 2011 was Healthcare IT with $10.25 billion worth of transactions.

"The healthcare information and technology ("HIT") mergers and acquisitions market was robust in 2011 as buyers looked to acquire rapidly growing companies, principally software enabled solutions (SaaS and Cloud enabled), in highly attractive niches to accelerate their own growth and offer fuller suites of world class products to the dynamic and growing healthcare marketplace," said Tom O'Connor, Managing Director in Berkery Noyes' Healthcare and Life Sciences group. "In 2012, we expect to see an increased deal flow and attractive prices for sellers from both strategic and financial buyers, but strategic buyers, like in 2011, will dominate the buyer universe."

According to Jonathan Krieger, Managing Director in Berkery Noyes' Healthcare and Life Sciences group, "The number of HIT transactions increased for the 3rd consecutive year and valuation multiples continued to rise. The enactment of the HITECH Act has catalyzed the adoption of IT by both payors and providers and has resulted in a very favorable M&A market for private companies that wish to pursue liquidity events."

Berkery Noyes specializes in structuring debt and equity transactions in the $25 million to $500 million range, a market that is enjoying a surge in activity. Unique among investment banking firms, Berkery Noyes combines independent strategic research and industry intelligence with senior information technology banking expertise. Long having been an innovator in database and research technology in M&A, Berkery Noyes has committed itself to providing more expansive and current information. The firm's research teams publish acquisition activity in the respective sectors they follow on MandAsoft.com.

A copy of the FULL YEAR 2011 PHARMA & HEALTHCARE INFORMATION AND TECHNOLOGY INDUSTRY M&A TREND REPORT is available at the Berkery Noyes website.

About Berkery Noyes

Berkery Noyes is an independent investment banking advisory firm servicing the information industry. Focused on middle-market corporations and financial sponsors, Berkery Noyes is committed to delivering a comprehensive array of industry-leading advisory services. Since its founding by Joseph W. Berkery in 1983, the firm has worked with corporate clients to grow through acquisition, divest non-core assets, and maximize shareholder returns through strategic transactions and restructurings. For private owners, Berkery Noyes helps create liquidity and execute timely exit strategies that achieve their personal and professional objectives. For more information, visit www.berkerynoyes.com.

Contact Information:
Peter Wilson
Berkery Noyes
646-442-7966
peter.wilson@berkerynoyes.com

 

 

 


'/>"/>
SOURCE Berkery Noyes
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Berkery Noyes Represented The Thomson Corporation in the Sale of CenterWatch and New England Institutional Review Board to Jobson Medical Information
2. Berkery Noyes Releases 2009 Pharma and Healthcare Information Merger & Acquisition Trends
3. Berkery Noyes Releases First Half 2011 M&A Report for the Pharma and Healthcare Information and Technology Industry
4. Berkery Noyes Releases Third Quarter 2011 Mergers & Acquisitions Update for the Pharma and Healthcare Information and Technology Industry
5. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
6. CEL-SCI Corporation Releases Letter to Shareholders
7. AcroMetrix Releases New OptiQuant(R) HIV-1 Quantification Panel
8. Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals
9. Immunosyn Corporation Releases SF-1019 Study Results
10. TCS Healthcare Technologies Releases Three New Clinical Care Programs Within ACUITY
11. Immunosyn Releases Wound Healing Photographs From the First Phase Proof of Concept Trial in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... 2016 Homozygous Familial Hypercholesterolemia (HoFH) ... Global Markets Direct,s latest Pharmaceutical and ... (HoFH) – Pipeline Review, H2 2016, provides ... (HoFH) (Metabolic Disorders) pipeline landscape. Homozygous ... is caused due to mutation from both ...
(Date:12/6/2016)... LONDON , Dec. 6, 2016 ... report provides in-depth region wise and country wise ... this report include manufacturers of human vaccines products, ... players planning to enter the market. The ... global human vaccines market. Qualitative analysis comprises market ...
(Date:12/6/2016)... , Dec. 6, 2016  Nearly 30 million people ... from the epidemic of diabetes. 1 However, nearly ... elevated glucose levels (hyperglycemia) and significant glucose variability. 2 ... complications, including cardiovascular events. If left untreated, hyperglycemia can ... eye disease or blindness. 3 As ...
Breaking Medicine Technology:
(Date:12/7/2016)... , ... December 07, 2016 , ... They are musicians ... sisters and wives, brothers and fathers, from New England and around the nation. What ... stigma, and are brought together in a beautiful and compelling new photographic exhibit debuting ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... ... financial consultation services from offices located in South Lyon, Dewitt, Williamston, East Lansing, ... a basketball coach who needs treatment for a brain tumor. , Jason Bauer ...
(Date:12/7/2016)... PA (PRWEB) , ... December 07, 2016 , ... One ... regular changing of the securement tape is painful for her. "This is why the ... to patients’ heads," she said. , They then created a prototype of the patent-pending ...
(Date:12/7/2016)... ... OCTOBER XX, 2016 (PRWEB) (PRWEB) December 07, 2016 , ... ... “Canine Filamentous Dermatitis Associated with Borrelia Infection” reveals that a condition ... in the prestigious Journal of Veterinary Science & Medical Diagnosis. , Morgellons disease ...
(Date:12/7/2016)... ... December 07, 2016 , ... Facial plastic surgeon, Dr. John ... by donating a portion of proceeds to two local organizations: North Chicago Animal Control ... & Friends is a team of authorized and trained volunteers who support rescued ...
Breaking Medicine News(10 mins):